Seaport Therapeutics, Inc. Common Stock

NASDAQ:SPTX

Biotechnology

Healthcare
$18.31 +0.58%

+$0.10 today

Market cap
$980.14M
Beta
0.00
52W Low $14.85High $23.00

Volume 0.68M

Average 0.41M

SPTX Capital Expenditures

Cash spent on property, plant, equipment, and other long-term assets.

No reported Capital Expenditures figures are available to summarize.

Capital Expenditures history

Currency unavailable · from the cash flow

No Capital Expenditures data reported for this period type.

Capital Expenditures vs competitors

How SPTX compares with its peers on the latest reported figures

SPTX Competitors
Capital Expenditures for SPTX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
VNDAVanda Pharmaceuticals Inc.LTM Mar 2026$783K USD-14.8%+13.7%0.4%
MPLTMapLight Therapeutics, Inc.LTM Mar 2026$497K USD-35.3%-14.1%—
CTNMContineum Therapeutics, Inc. Class A Common StockLTM Mar 2026$496K USD+19.8%+25.1%—
RAPPRapport Therapeutics, Inc. Common StockLTM Mar 2026$411K USD-74.7%+29.4%2.1%
GHRSGH Research PLCLTM Mar 2026$181.36K USD+342.3%+21.8%—
LBRXLB Pharmaceuticals Inc Common StockLTM Mar 2026$78K USD———
NMRANeumora Therapeutics, Inc. Common StockLTM Mar 2026$16K USD———
SPTXSeaport Therapeutics, Inc. Common Stock—— ———
Peer median (excluding SPTX) —-14.8%+21.8%1.2%

Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Seaport Therapeutics, Inc. Common Stock

NASDAQ:SPTX

Intrinsic Alpha fair value

Locked

Current Price

$18.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.